Back to search

Virginia Commonwealth University

THE DEVELOPMENT OF NOVEL INHIBITORS OF THE NLRP3 INFLAMMASOME

Abstract

dc:description.abstract

Inflammasomes are intracellular multimeric protein complexes that regulate inflammation by controlling the maturation of cytokines, interleukin-1β (IL-1β) and interleukin-18 (IL-18). Additionally, activation of these inflammasome complexes has been implicated in an inflammatory form of death known as proptosis. Of the known inflammasomes, the NOD-like receptor family pyrin domain containing 3 (NLPP3) inflammasome, is the most elucidated. Under physiological conditions, NLRP3-mediated inflammation promotes healing and the elimination of cellular debris and pathogens. However, the dysregulation of IL-1β, IL-18 and pyroptosis are instrumental in the development of multiple pathologies. Furthermore, studies suggest that the NLRP3 inflammasome mediates detrimental neuroinflammation and contributes significantly to the development of several neurodegenerative diseases. This includes Alzheimer’s disease, multiple sclerosis, Parkinson's disease, and amyotrophic lateral sclerosis. Novel NLRP3 inflammasome inhibitors (NLRP3Is) are needed as pharmacological tools to complement ongoing molecular and genetic studies to aid in defining the roles of NLRP3 in neurological diseases. Development of such inhibitors also has significant translational potential. In order to develop novel small molecule inhibitors of the NLRP3 inflammasome, we conducted an in-depth structure-activity-relationship study of a known NLRP3 inhibitor. Two new lead compounds, 54 and 64, were identified. These compounds were potent and selective NLRP3 inhibitors in both in BMDMs and J774A.1 cell-lines. Importantly, a study utilizing mice challenged with LPS demonstrated that both of these compounds have in vivo activity. Collectively, these results strongly encourage further development of new analogs based on this promising chemical scaffold.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Pharmacy - Dean's Office

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Fulp, Jacob W
  • <p>0000-0003-0695-3155</p>
Contributors dc:contributor
  • Dr. Shijun Zhang

Rights

dc:rights
Statement dc:rights
  • © The Author

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Virginia Commonwealth University
Base URL
scholarscompass.vcu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Fulp, Jacob W; <p>0000-0003-0695-3155</p>. THE DEVELOPMENT OF NOVEL INHIBITORS OF THE NLRP3 INFLAMMASOME. Dissertation thesis, https://doi.org/10.25772/F95W-R440